Clinical Trials Directory

Trials / Conditions / Stage II Rectal Cancer

Stage II Rectal Cancer

11 registered clinical trials studyying Stage II Rectal Cancer — 1 currently recruiting.

StatusTrialSponsorPhase
CompletedDasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Ca
NCT04164069
Anne NoonanPhase 1
CompletedHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
NCT03154190
Stanford UniversityN/A
RecruitingNo Surgery Trial / Two Dose-escalation Strategies
NCT03051464
Sir Mortimer B. Davis - Jewish General HospitalPhase 2 / Phase 3
CompletedLow Glycemic Load Diet in Patients With Stage I-III Colon Cancer
NCT02129218
Case Comprehensive Cancer CenterN/A
WithdrawnLaparoscopic Surgery or Robotic-Assisted Laparoscopic Surgery in Treating Patients With Rectal Cancer That Can
NCT01196000
City of Hope Medical CenterN/A
WithdrawnAltered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarci
NCT01302613
University of Texas Southwestern Medical CenterPhase 1 / Phase 2
CompletedResveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery
NCT00433576
National Cancer Institute (NCI)Phase 1
TerminatedPostoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
NCT00303628
ECOG-ACRIN Cancer Research GroupPhase 3
TerminatedEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
NCT00087191
National Cancer Institute (NCI)N/A
CompletedBevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III
NCT00052559
National Cancer Institute (NCI)Phase 1
CompletedOxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With L
NCT00006094
National Cancer Institute (NCI)Phase 1 / Phase 2